HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Bischofberger Selected Research

Infections

11/2001Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.
8/2001Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.
1/2001Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
1/2001Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
1/2001Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment.
11/2000Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
10/2000Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.
8/2000Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.
7/2000Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys.
3/2000Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Bischofberger Research Topics

Disease

11Infections
11/2001 - 02/2000
7Viremia
08/2003 - 02/2000
3Acquired Immunodeficiency Syndrome (AIDS)
11/2001 - 02/2000
2Virus Diseases (Viral Diseases)
08/2000 - 02/2000
1HIV Infections (HIV Infection)
08/2000
1Persistent Infection
03/2000

Drug/Important Bio-Agent (IBA)

7Tenofovir (Viread)FDA Link
08/2003 - 02/2000
3Pharmaceutical PreparationsIBA
11/2001 - 02/2000
3AdenineFDA LinkGeneric
08/2001 - 03/2000
3Reverse Transcriptase InhibitorsIBA
08/2001 - 08/2000
2Antiviral Agents (Antivirals)IBA
07/2000 - 02/2000
1RNA (Ribonucleic Acid)IBA
08/2003
1VaccinesIBA
11/2001
1Neutralizing AntibodiesIBA
11/2001
1Monoclonal AntibodiesIBA
11/2001
1Explosive Agents (Explosives)IBA
01/2001
1Viral RNAIBA
11/2000
1NucleosidesIBA
08/2000
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2000
1ChemokinesIBA
07/2000

Therapy/Procedure

2Therapeutics
01/2001 - 02/2000
2Withholding Treatment
01/2001 - 03/2000
1Highly Active Antiretroviral Therapy (HAART)
01/2001
1Art Therapy
10/2000
1Chemoprevention
08/2000
1Drug Therapy (Chemotherapy)
02/2000